Physicochemical Characterization and Drug Release Properties of Methyl-Substituted Silica Xerogels Made Using Sol-Gel Process.
Captopril
controlled release
hybrid silica materials
nanostructure
sol–gel technique
structural characterization
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 Aug 2021
25 Aug 2021
Historique:
received:
03
08
2021
revised:
21
08
2021
accepted:
22
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
14
10
2021
Statut:
epublish
Résumé
In this work, a multi-analytical approach involving nitrogen porosimetry, small angle neutron and X-ray scattering, Fourier transform infrared (FTIR) and nuclear magnetic resonance (NMR) spectroscopies, X-ray diffraction, thermal analysis and electron microscopy was applied to organically modified silica-based xerogels obtained through the sol-gel process. Starting from a tetraethoxysilane (TEOS) precursor, methyltriethoxysilane (MTES) was added to the reaction mixture at two different pH values (2.0 and 4.5) producing hybrid xerogels with different TEOS/MTES molar ratios. Significant differences in the structure were revealed in terms of the chemical composition of the silica network, hydrophilic/hydrophobic profile, particle dimension, pore shape/size and surface characteristics. The combined use of structural characterization methods allowed us to reveal a relation between the cavity dimensions, the synthesis pH value and the grade of methyl substitution. The effect of the structural properties on the controlled Captopril release efficiency has also been tested. This knowledge facilitates tailoring the pore network for specific usage in biological/medical applications. Knowledge on structural aspects, as reported in this work, represents a key starting point for the production of high-performance silica-based hybrid materials showing enhanced efficacy compared to bare silica prepared using only TEOS.
Identifiants
pubmed: 34502104
pii: ijms22179197
doi: 10.3390/ijms22179197
pmc: PMC8430635
pii:
doi:
Substances chimiques
Nanocapsules
0
Silanes
0
Silica Gel
60650-90-0
Captopril
9G64RSX1XD
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Control Release. 2001 Jun 15;73(2-3):121-36
pubmed: 11516493
Drug Deliv. 2007 Aug;14(6):337-47
pubmed: 17701523
Nanoscale. 2017 Feb 9;9(6):2253-2261
pubmed: 28124705
Curr Med Chem. 2018;25(12):1409-1419
pubmed: 28393698
Adv Drug Deliv Rev. 2012 Dec;64(15):1800-19
pubmed: 22634160
ACS Omega. 2020 Jul 24;5(30):18842-18848
pubmed: 32775886
Chem Soc Rev. 2016 Jun 13;45(12):3377-99
pubmed: 26563577
Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:43-52
pubmed: 26652347
Int J Pharm. 2012 Oct 15;436(1-2):111-9
pubmed: 22743006
Materials (Basel). 2018 Apr 06;11(4):
pubmed: 29642404
Acta Biomater. 2020 Mar 15;105:131-145
pubmed: 31953196
Molecules. 2018 Aug 13;23(8):
pubmed: 30104542
Drug Discov Today Technol. 2018 Jul;27:71-80
pubmed: 30103866
Expert Opin Drug Deliv. 2016;13(1):93-108
pubmed: 26549623
Methods Mol Biol. 2021;2207:99-108
pubmed: 33113130
J Control Release. 2021 Apr 10;332:40-63
pubmed: 33600880
Nanomaterials (Basel). 2020 May 20;10(5):
pubmed: 32443655
J Colloid Interface Sci. 2009 Apr 15;332(2):484-90
pubmed: 19200554
J Agric Food Chem. 2019 Oct 23;67(42):11553-11567
pubmed: 31553885
J Control Release. 2011 Nov 7;155(3):409-17
pubmed: 21763374
Colloids Surf B Biointerfaces. 2019 Apr 1;176:212-218
pubmed: 30623808
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Dec 10;133:619-25
pubmed: 24992921